Literature DB >> 17331444

[Expression of HOXC13 in ameloblastoma].

Ming Zhong1, Jie Wang, Yan-bing Gong, Jin-cheng Li, Bo Zhang, Lin Hou.   

Abstract

OBJECTIVE: To study the expression of HOXC13 mRNA in ameloblastoma (AB), and to investigate its biological significance.
METHODS: HOXC13 mRNA was examined in 47 cases of AB (primary AB 29 cases, recurrent AB 14 cases, malignant AB 4 cases). 2 cases of fibrous dysplasia of bone, 10 cases of keratocystic odontogenic tumor (KCOT) and 7 cases of normal oral mucosa were selected as control.
RESULTS: The positive rates of HOXC13 mRNA in AB, KCOT, and normal oral mucosa were 97.9% (46/47), 7/10 and 3/7, respectively. There was a significant difference among AB, OKC and normal mucosa (chi(2) = 21.665, P = 0.001). For HOXC13, the keratinizing cells and granulizing cells in AB were negative, some fibroblasts were positive, 2 cases of fibrous dysplasia of bone were positive.
CONCLUSIONS: HOXC13 was highly expressed in AB. The expression of HOXC13 mRNA in AB had heterogeneity, which could improve the epithelial proliferation, and its loss may lead to the cornification and degeneration of epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331444

Source DB:  PubMed          Journal:  Zhonghua Kou Qiang Yi Xue Za Zhi        ISSN: 1002-0098


  5 in total

1.  HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1.

Authors:  Yu Yao; Jing Luo; Qi Sun; Ting Xu; Siqing Sun; Meili Chen; Xin Lin; Qiuping Qian; Yu Zhang; Lin Cao; Po Zhang; Yong Lin
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

2.  HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3.

Authors:  Jing Luo; Zhongqiu Wang; Jianfeng Huang; Yu Yao; Qi Sun; Jie Wang; Yi Shen; Lin Xu; Binhui Ren
Journal:  Cancer Sci       Date:  2017-12-20       Impact factor: 6.716

3.  Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis.

Authors:  Lijie Chen; Guannan Wang; Xue Qiao; Xiaobin Wang; Jinwen Liu; Xing Niu; Ming Zhong
Journal:  Med Sci Monit       Date:  2020-01-28

4.  Landscape of N6-Methyladenosine Modification Patterns in Human Ameloblastoma.

Authors:  Xing Niu; Jingping Xu; Jinwen Liu; Lijie Chen; Xue Qiao; Ming Zhong
Journal:  Front Oncol       Date:  2020-10-14       Impact factor: 6.244

5.  A Novel lncRNA ENST00000512916 Facilitates Cell Proliferation, Migration and Cell Cycle Progression in Ameloblastoma.

Authors:  Yan Sun; Xing Niu; Guannan Wang; Xue Qiao; Lijie Chen; Ming Zhong
Journal:  Onco Targets Ther       Date:  2020-02-19       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.